These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34589445)

  • 1. Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.
    Gandhi M; Ling WH; Chen CH; Lee JH; Kudo M; Chanwat R; Strasser SI; Xu Z; Lai SH; Chow PK
    J Hepatocell Carcinoma; 2021; 8():1159-1167. PubMed ID: 34589445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
    Amaddeo G; Brustia R; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Séror O; Larrey E; Lim C; Scatton O; El Mouhadi S; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Vilgrain V; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Roudot-Thoraval F; Bouattour M; Nault JC;
    JHEP Rep; 2021 Feb; 3(1):100199. PubMed ID: 33163949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
    Choi C; Choi GH; Kim TH; Tanaka M; Meng MB; Seong J
    Liver Cancer; 2014 Oct; 3(3-4):405-16. PubMed ID: 26280002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
    Chen LJ; Chang YJ; Chang YJ
    Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
    Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
    Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
    World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver resection for HCC outside the BCLC criteria.
    Bhandare MS; Patkar S; Shetty N; Polnaya A; Kulkarni S; Dusane RR; Shrikhande SV; Goel M
    Langenbecks Arch Surg; 2018 Feb; 403(1):37-44. PubMed ID: 29199380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.
    De Souza S; Kahol de Jong J; Perone Y; Shetty S; Qurashi M; Vithayathil M; Shah T; Ross P; Temperley L; Yip VS; Banerjee A; Bettinger D; Sturm L; Reeves HL; Geh D; Orr J; Allen B; Jones RP; Sharma R
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
    Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
    BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
    Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
    World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
    Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
    Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical stages of recurrent hepatocellular carcinoma: A retrospective cohort study.
    Yao SY; Liang B; Chen YY; Tang YT; Dong XF; Liu TQ
    World J Clin Cases; 2021 Sep; 9(27):8020-8026. PubMed ID: 34621858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.
    Koh YX; Tan HL; Lye WK; Kam JH; Chiow AKH; Tan SS; Choo SP; Chung AYF; Goh BKP
    World J Hepatol; 2018 Jun; 10(6):433-447. PubMed ID: 29988922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology.
    Liu PH; Hsu CY; Lee YH; Su CW; Hsia CY; Huang YH; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2015 Oct; 94(41):e1772. PubMed ID: 26469917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLC.
    Guiu B; Garin E; Allimant C; Edeline J; Salem R
    Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1599-1607. PubMed ID: 35149884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Platelet to Lymphocyte Ratio between Degrees of the Barcelona Clinic Liver Cancer on Hepatocellular Carcinoma Patients at Haji Adam Malik General Hospital.
    Siregar GA; Irwansyah D
    Open Access Maced J Med Sci; 2019 Oct; 7(20):3451-3454. PubMed ID: 32002072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.
    Richani M; Kolly P; Knoepfli M; Herrmann E; Zweifel M; von Tengg-Kobligk H; Candinas D; Dufour JF
    Ann Hepatol; 2016; 15(1):82-90. PubMed ID: 26626644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
    Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.
    Ye JZ; Wang YY; Bai T; Chen J; Xiang BD; Wu FX; Li LQ
    Oncotarget; 2017 Nov; 8(54):93258-93278. PubMed ID: 29190996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.